Dysregulation of the TLR-NF-κB signaling pathway has been linked to various inflammation-related diseases, including rheumatoid arthritis, IBD, and systemic lupus erythematosus [55, 56]. Here, NFKB1 is linked to systemic lupus erythematosus.